All entries for: ProMIS Neurosciences

March 25, 2026

ProMIS Neurosciences

Neutral Outlook

Ontario, Canada
1-50 employees

The effect the IRA will have on our business and the pharmaceutical industry in general is not yet known.

Disease Area: Neurological Diseases
Drug Type: Biologic
Scroll to Top